Diomed seeks injunction against Total Vein Solutions:
This article was originally published in Clinica
Manufacturer of minimally-invasive medical technologies Diomed has filed for a preliminary injunction against Total Vein Solutions (TVS), a venous surgery product developer headquartered in Houston, Texas, in a bid to enforce a patent covering endovascular laser treatment of varicose veins. The company initiated the lawsuit against TVS in 2004. Diomed (Andover, Massachusetts) filed for injunctive relief and damages in the US federal district court for the district of Massachusetts with Judge Nathaniel Gorton, who previously ruled in the company's favour over injunctions against Vascular Solutions and AngioDynamics concerning the same patent (see Clinica No 1263, p 13).
You may also be interested in...
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.
Sangamo licensed Biogen zinc finger protein transcription factor candidates in an alliance worth over $2bn. Exercising an option it gained in 2017, Takeda bought celiac disease-focused PvP Biologics for up to $330m in earn-outs. A strong showing of IPOs prompted biopharma financing to increase from last month.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.